PROGRESSION OF DIABETIC RETINOPATHY IN PATIENTS AFTER COVID-19

Authors

  • Azamat F. Yusupov, Shirin A. Djamalova DSc, Associated professor, Republican Specialized Scientific and Practical Medical Center of Eye Microsurgery, Tashkent, Uzbekistan.
  • Narzikul Kh. Makhmudov PhD researcher, Republican Specialized Scientific and Practical Eye Microsurgery Medical Center, Tashkent, Uzbekistan.

Keywords:

COVID-19; diabetic retinopathy; progression.

Abstract

Research Objective: assessment of the degree of progression of diabetic retinopathy (DR) in patients who have had a coronavirus infection.

Methods. A retrospective and prospective analysis of the severity of DR was performed in 84 patients with type 2 diabetes mellitus who underwent COVID-19. Based on a comparative analysis of the dynamics of the disease during the pandemic (2020-2021) and the “pre-pandemic period” (2018-2019).

Results. In persons who underwent COVID-19, the progression of the stages of non-proliferative retinopathy prevailed. In most cases, there was a transition from the mild stage of non-proliferative retinopathy to moderate and moderate to severe.

Conclusion. Postponed COVID-19 contributes to a significant progression in the form of an increase in the level of the non-proliferative stage of DR

Downloads

Published

-

How to Cite

Azamat F. Yusupov, Shirin A. Djamalova, & Narzikul Kh. Makhmudov. (2023). PROGRESSION OF DIABETIC RETINOPATHY IN PATIENTS AFTER COVID-19. EPRA International Journal of Multidisciplinary Research (IJMR), 9(7), 346–348. Retrieved from http://eprajournals.net/index.php/IJMR/article/view/2509

Issue

Vol. 9 No. 7 (2023): EPRA International Journal of Multidisciplinary Research (IJMR)

Section

Articles